MICHAELA MILLER-BERGERON: Open Payments
NPI 1194563064 · FISHERSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,105 in 89 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $202 · 2025 $2,105
Food & beverage: $2,105
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $675 |
| Janssen Biotech, Inc. | 15 | $289 |
| QOL Medical, LLC | 5 | $140 |
| Madrigal Pharmaceuticals | 3 | $140 |
| Aimmune Therapeutics, Inc. | 4 | $136 |
| Ardelyx, Inc. | 6 | $100 |
| Phathom Pharmaceuticals, Inc. | 5 | $86 |
| Lilly USA, LLC | 4 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $76 |
| GENZYME CORPORATION | 2 | $67 |
Products named: RINVOQ, SKYRIZI, TREMFYA, Sucraid, REZDIFFRA, IBSRELA, VOWST, VOQUEZNA.
Industry payments across VA — which companies pay providers there.
